Inventor
HE LIQI
US27 patents
⚠️ This page may combine multiple inventors who share the name “HE LIQI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
20 patentsUS10494370B2Dec 3, 2019
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO15 citations94
US10487084B2Nov 26, 2019
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO16 citations94
US9273057B2Mar 1, 2016
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO29 citations93
US10508115B2Dec 17, 2019
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO13 citations92
US11554120B2Jan 17, 2023
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
BRISTOL MYERS SQUIBB CO4 citations74
US11400094B2Aug 2, 2022
2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
BRISTOL MYERS SQUIBB CO4 citations73
US9556178B2Jan 31, 2017
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US10927114B2Feb 23, 2021
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO0 citations62
US10919895B2Feb 16, 2021
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO0 citations62
US10913741B2Feb 9, 2021
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO0 citations62
US8940736B2Jan 27, 2015
Imidazotriazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US7923556B2Apr 12, 2011
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US12485123B2Dec 2, 2025
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists
BRISTOL MYERS SQUIBB CO0 citations52
US10793569B2Oct 6, 2020
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO0 citations52
US10723736B2Jul 28, 2020
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO0 citations52
US10711003B2Jul 14, 2020
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO0 citations52
US10689382B2Jun 23, 2020
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
BRISTOL MYERS SQUIBB CO0 citations52
US11485741B2Nov 1, 2022
Macrocyclic toll-like receptor 7 (TLR7) agonists
BRISTOL MYERS SQUIBB CO0 citations51
US7094782B1Aug 22, 2006
Azolo triazines and pyrimidines
BRISTOL MYERS SQUIBB CO1 citations51
US9371328B2Jun 21, 2016
Imidazopyridazinecarbonitriles useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations50